Franklin
Genomic intelligence platform for precision medicine
Platform · Cloud SaaSCompany source
Company profile
About Genoox
Genoox is a precision medicine and genomics company that develops platforms for genomic data management and clinical interpretation. The company's flagship product, Franklin, serves as a comprehensive genomic analysis platform designed to help healthcare organizations, laboratories, and researchers interpret genetic variants and translate genomic data into actionable clinical insights. Genoox focuses on enabling precision medicine by providing tools that streamline the analysis of complex genomic information, support variant classification, and facilitate the integration of genomic findings into patient care pathways. The platform is designed to serve clinical geneticists, molecular pathologists, genetic counselors, and research scientists working across various medical specialties. By combining advanced bioinformatics with clinical decision support capabilities, Genoox aims to accelerate the adoption of genomic medicine in routine healthcare settings and support the growing demand for personalized treatment approaches based on individual genetic profiles.
Company description Genoox official website
Primary marketPrecision Medicine & Genomics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Genoox?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- cancer genomics
- genetic disorders
- hereditary conditions
Who it serves
- Clinical Laboratories
- Genetic Testing Labs
- Healthcare Organizations
- Research Institutions
Deployment & integration
Cloud Saas deployment with recorded integration context.
Geographic context
MarketsNot currently listed
Company sourceOfficial website
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
European Reference Networks as core health structures where referring genetic newborn screening positive infants: an innovative operational research framework.Frontiers in public health · Jan 1, 2026
TREAT: systematic and inclusive selection process of genes for genomic newborn screening as part of the Screen4Care project.Orphanet journal of rare diseases · May 15, 2025
Defining and pursuing diversity in human genetic studies.Nature genetics · Oct 1, 2024
Applying data science methodologies with artificial intelligence variant reinterpretation to map and estimate genetic disorder prevalence utilizing clinical data.American journal of medical genetics. Part A · May 1, 2024
Community data-driven approach to identify pathogenic founder variants for pan-ethnic carrier screening panels.Human genomics · Mar 28, 2023
Genetic newborn screening and digital technologies: A project protocol based on a dual approach to shorten the rare diseases diagnostic path in Europe.PloS one · Jan 1, 2023
Clinical validation
Clinical-trial records
Genetic Newborn Screening for Rare Diseases Within the Screen4Care ProjectNCT06549218 · Sponsor · RECRUITING
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Genoox
Recent articles published on Genoox's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Precision Medicine & Genomics
Companies using AI to analyze genomic, proteomic, metabolomic, or multi-omics data to provide personalized treatment recommendations, identify genetic risks, or develop targeted therapies. Includes genomic sequencing platforms with AI analysis, preventive medicine based on genetic risk assessment, and longevity care based on molecular and genetic data.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.